Eurofins Scientific SE (LON:0MV5)
61.04
+0.32 (0.53%)
At close: Oct 31, 2025
Eurofins Scientific SE Revenue
Eurofins Scientific SE had revenue of 3.61B EUR in the half year ending June 30, 2025, with 12.54% growth. This brings the company's revenue in the last twelve months to 7.14B, up 6.25% year-over-year. In the year 2024, Eurofins Scientific SE had annual revenue of 6.95B with 6.70% growth.
Revenue (ttm)
7.14B EUR
Revenue Growth
+6.25%
P/S Ratio
1.55
Revenue / Employee
113.95K EUR
Employees
62,696
Market Cap
9.52B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.95B | 436.40M | 6.70% |
| Dec 31, 2023 | 6.51B | -197.50M | -2.94% |
| Dec 31, 2022 | 6.71B | -5.60M | -0.08% |
| Dec 31, 2021 | 6.72B | 1.28B | 23.51% |
| Dec 31, 2020 | 5.44B | 876.00M | 19.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |